CTLA4 and cancer: Lately, the realm of immune intervention techniques focused on immune checkpoint molecules like PD-1 and cytotoxic t-lymphocyte associated antigen 4 (CTLA4) has offered fresh hope for treating associated disorders, especially cancer.